CRISPR Interference-Based Platform for Multimodal Genetic Screens in Human iPSC-Derived Neurons

Tian, Ruilin, Gachechiladze, Mariam A., Ludwig, Connor H., Laurie, Matthew T., Hong, Jason Y., Nathaniel, Diane, Prabhu, Anika V., Fernandopulle, Michael S. +4 more·2019·Neuron

Cited by (556)

Items 101–200 of 556

  1. mTOR activation induces endolysosomal remodeling and nonclassical secretion of IL-32 via exosomes in inflammatory reactive astrocytes
    Kun Leng, Brendan Rooney, Frank McCarthy, Wenlong Xia, Indigo V.L. Rose, Sophie Bax, Marcus Y. Chin, Saeed Fathi, Kari A. Herrington, Manuel D. Leonetti et al. · 2024 · Journal of Neuroinflammation
  2. CRISPRi-based screens in iAssembloids to elucidate neuron-glia interactions
    Emmy Li, Camila Benitez, Steven C. Boggess, Mark Koontz, Indigo V.L. Rose, Delsy Martinez, Nina M. Dräger, Olivia M. Teter, Avi J. Samelson, Na’im Pierce et al. · 2025 · Neuron
  3. Characterizing and controlling CRISPR repair outcomes in nondividing human cells
    Gokul N. Ramadoss, Samali J. Namaganda, Manasi M. Kumar, Jennifer R. Hamilton, Rohit Kumar Sharma, Karena G. Chow, Luke A. Workley, Bria L Macklin, Mengyuan Sun, Alvin S. Ha et al. · 2025 · Nature Communications
  4. Genome-scale perturb-seq in primary human CD4+ T cells maps context-specific regulators of T cell programs and human immune traits
    Ronghui Zhu, Emma Dann, Jun Yan, Justine Reyes Retana, Ryunosuke Goto, Reese C Guitche, Lillian Brixi, Mineto Ota, Austin Hartman, Theodore L. Roth et al. · 2026 · Cell
  5. Generation and validation of versatile inducible CRISPRi embryonic stem cell and mouse model
    Rui Li, Xianyou Xia, Xing Wang, Xiaoyu Sun, Zhongye Dai, Dawei Huo, Huimin Zheng, Haiqing Xiong, Aibin He, Xudong Wu · 2020 · PLoS Biology
  6. RETRACTED: Orientin, a Bio-Flavonoid from Trigonella hamosa L., Regulates COX-2/PGE-2 in A549 Cell Lines via miR-26b and miR-146a
    Hany Ezzat Khalil, Hairul-Islam Mohamed Ibrahim, Emad A. Ahmed, Promise Madu Emeka, Ibrahim Abdulrahman Alhaider · 2022 · Pharmaceuticals · Retracted
  7. C-terminal amides mark proteins for degradation via SCF–FBXO31
    Matthias Muhar, Jakob Farnung, Martina Cernakova, Raphael Hofmann, Lukas T. Henneberg, Moritz M. Pfleiderer, Annina Denoth‐Lippuner, Filip Kalčic, Ajse S. Nievergelt, Marwa al‐Bayati et al. · 2025 · Nature
  8. Induced Pluripotent Stem Cells in Psychiatry: An Overview and Critical Perspective
    Alejandro De Los Angeles, Michael B. Fernando, Nicola Hall, Kristen Brennand, Paul J. Harrison, Brady J. Maher, Daniel R. Weinberger, Elizabeth M. Tunbridge · 2021 · Biological Psychiatry
  9. Probabilistic machine learning ensures accurate ambient denoising in droplet-based single-cell omics
    Caibin Sheng, Rui Lopes, Gang Li, Sven Schuierer, Annick Waldt, Rachel Cuttat, Slavica Dimitrieva, Audrey Kauffmann, Eric Durand, Giorgio G. Galli et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  10. Human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) for modeling cardiac arrhythmias: strengths, challenges and potential solutions
    Joshi, Jyotsna, Albers, Cora, Smole, Nathan, Guo, Shuliang, Smith, Sakima A. · 2024 · Frontiers in Physiology
  11. Epigenetic reprogramming shapes the cellular landscape of schwannoma
    Siyuan John Liu, Tim Casey-Clyde, Nam Woo Cho, Jason T. Swinderman, Melike Pekmezci, Mark C. Dougherty, Kyla J. Foster, William Chen, Javier E. Villanueva-Meyer, Danielle L. Swaney et al. · 2024 · Nature Communications
  12. Comparative landscape of genetic dependencies in human and chimpanzee stem cells
    Richard She, Tyler Fair, Nathan K. Schaefer, Reuben A. Saunders, Bryan J. Pavlovic, Jonathan S. Weissman, Alex A. Pollen · 2023 · Cell
  13. CRISPR applications in cancer diagnosis and treatment
    Mingxia Wang, Menghui Chen, Xia Wu, Xinbo Huang, Bo Yu · 2023 · Cellular & Molecular Biology Letters
  14. Single-molecule imaging reveals distinct elongation and frameshifting dynamics between frames of expanded RNA repeats in C9ORF72-ALS/FTD
    Malgorzata J. Latallo, Shaopeng Wang, Daoyuan Dong, Blake Nelson, Nathan M. Livingston, Rong Wu, Ning Zhao, Timothy J. Stasevich, Michael Cory Bassik, Shuying Sun et al. · 2023 · Nature Communications
  15. Rare variation in non-coding regions with evolutionary signatures contributes to autism spectrum disorder risk
    Taehwan Shin, Janet H. T. Song, Michael Kosicki, Connor J. Kenny, Samantha G. Beck, Lily Kelley, Irene Antony, Xuyu Qian, Julieta Bonacina, Frances Papandile et al. · 2024 · Cell Genomics
  16. Disruption of nuclear speckle integrity dysregulates RNA splicing in C9ORF72-FTD/ALS
    Rong Wu, Yingzhi Ye, Daoyuan Dong, Zhe Zhang, Shaopeng Wang, Yini Li, Noelle Wright, Javier Redding‐Ochoa, Koping Chang, Shaohai Xu et al. · 2024 · Neuron
  17. An integrative systems-biology approach defines mechanisms of Alzheimer’s disease neurodegeneration
    Matthew Joseph Leventhal, Camila A. Zanella, Byunguk Kang, Jiajie Peng, David Gritsch, Zhixiang Liao, Hassan Bukhari, Tao Wang, Ping‐Chieh Pao, Serwah A. Danquah et al. · 2025 · Nature Communications
  18. Repetitive mild head trauma induces activity mediated lifelong brain deficits in a novel Drosophila model
    Joseph A. Behnke, Changtian Ye, Aayush Setty, Kenneth H. Moberg, James Q. Zheng · 2021 · Scientific Reports
  19. Allele-specific silencing of the gain-of-function mutation in Huntington’s disease using CRISPR/Cas9
    Jun Wan Shin, Eun Pyo Hong, Seri S. Park, Doo Eun Choi, Ihn Sik Seong, Madelynn N. Whittaker, Benjamin P. Kleinstiver, Richard Z. Chen, Jong‐Min Lee · 2022 · JCI Insight
  20. Divergence, Convergence, and Therapeutic Implications: A Cell Biology Perspective of C9ORF72-ALS/FTD
    Xiaoqiang Tang, Arturo Toro, T. G. Sahana, Junli Gao, Jessica L Chalk, Björn Oskarsson, Ke Zhang · 2020 · Molecular Neurodegeneration
  21. Spastin locally amplifies microtubule dynamics to pattern the axon for presynaptic cargo delivery
    Jayne Aiken, Erika L.F. Holzbaur · 2024 · Current Biology
  22. Resolving Neurodevelopmental and Vision Disorders Using Organoid Single-Cell Multi-omics
    Giovanna Brancati, Barbara Treutlein, J. Gray Camp · 2020 · Neuron
  23. Histone acetylation in an Alzheimer’s disease cell model promotes homeostatic amyloid-reducing pathways
    Daniel C. Xu, Hanna Sas‐Nowosielska, Greg Donahue, Hua Huang, Naemeh Pourshafie, Charly Ryan Good, Shelley L. Berger · 2024 · Acta Neuropathologica Communications
  24. High-throughput screening for small-molecule stabilizers of misfolded glucocerebrosidase in Gaucher disease and Parkinson’s disease
    Darian Williams, Logan M. Glasstetter, Tiffany T. Jong, Tiffany Chen, Abhijeet Kapoor, Sha Zhu, Yanping Zhu, Raul Calvo, Alexandra Gehrlein, Kimberly Wong et al. · 2024 · Proceedings of the National Academy of Sciences
  25. The Interface of Gene Editing with Regenerative Medicine
    Veronica E. Farag, Elsie Devey, Kam W. Leong · 2024 · Engineering
  26. Reaching into the toolbox: Stem cell models to study neuropsychiatric disorders
    Jack T. Whiteley, Sarah Fernandes, Amandeep Sharma, Ana P. D. Mendes, Vipula Racha, Simone K. Benassi, Maria Carolina Marchetto · 2022 · Stem Cell Reports
  27. Genome-scale CRISPR-Cas9 screening in stem cells: theories, applications and challenges
    Heng Zhou, Ye Peng, Wei Xiong, Xingxiang Duan, Shuili Jing, Yan He, Zhi Rong Zeng, Yen Wei, Qingsong Ye · 2024 · Stem Cell Research & Therapy
  28. Allosteric HSP70 inhibitors perturb mitochondrial proteostasis and overcome proteasome inhibitor resistance in multiple myeloma
    Ian Ferguson, Yu-Hsiu Tony Lin, Christine Lam, Hao Shao, Kevin M. Tharp, Martina Hale, Corynn Kasap, Margarette C. Mariano, Audrey Kishishita, Bonell Patiño-Escobar et al. · 2022 · Cell chemical biology
  29. Pooled genetic screens with image‐based profiling
    Russell T. Walton, Avtar K Singh, Paul C. Blainey · 2022 · Molecular Systems Biology
  30. Modelling frontotemporal dementia using patient-derived induced pluripotent stem cells
    Georgie Lines, Jackie M. Casey, Elisavet Preza, Selina Wray · 2020 · Molecular and Cellular Neuroscience
  31. Deciphering pathogenicity of variants of uncertain significance with CRISPR-edited iPSCs
    Hongchao Guo, Lichao Liu, Masataka Nishiga, Le Cong, Joseph C. Wu · 2021 · Trends in Genetics
  32. Nuclear dynamics and stress responses in Alzheimer’s disease
    Artemis Iatrou, Eric M. Clark, Yanling Wang · 2021 · Molecular Neurodegeneration
  33. Mind the translational gap: using iPS cell models to bridge from genetic discoveries to perturbed pathways and therapeutic targets
    Greta Pintacuda, Jacqueline M. Martín, Kevin C. Eggan · 2021 · Molecular Autism
  34. Arrayed CRISPR reveals genetic regulators of tau aggregation, autophagy and mitochondria in Alzheimer’s disease model
    Lishu Duan, Mufeng Hu, Joseph A. Tamm, Yelena Y. Grinberg, Fang Shen, Yating Chai, Hualin Simon Xi, Lauren Gibilisco, Brinda Ravikumar, Vivek Gautam et al. · 2021 · Scientific Reports
  35. Unraveling Human Brain Development and Evolution Using Organoid Models
    Sarah Fernandes, Davis Klein, Maria Carolina Marchetto · 2021 · Frontiers in Cell and Developmental Biology
  36. Cerebral Organoids as an Experimental Platform for Human Neurogenomics
    Tomasz Jan Nowakowski, Sofie R. Salama · 2022 · Cells
  37. Escape from NK cell tumor surveillance by NGFR-induced lipid remodeling in melanoma
    Julia Lehmann, Nicole Caduff, Ewelina Krzywińska, Salome Stierli, Adrián Salas-Bastos, Benjamin Loos, Mitchell P. Levesque, Reinhard Dummer, Christian Stockmann, Christian Münz et al. · 2023 · Science Advances
  38. Pooled Genome-Scale CRISPR Screens in Single Cells
    Daniel Schraivogel, Lars Michael Steinmetz, Leopold Parts · 2023 · Annual Review of Genetics
  39. A high-throughput CRISPR interference screen for dissecting functional regulators of GPCR/cAMP signaling
    Khairunnisa Mentari Semesta, Ruilin Tian, Martin Kampmann, Mark von Zastrow, Nikoleta G. Tsvetanova · 2020 · PLoS Genetics
  40. Targeted CRISPR activation is functional in engineered human pluripotent stem cells but undergoes silencing after differentiation into cardiomyocytes and endothelium
    Elaheh Karbassi, Ruby Padgett, Alessandro Bertero, Hans Reinecke, Jordan M. Klaiman, Xiulan Yang, Stephen D. Hauschka, Charles E. Murry · 2024 · Cellular and Molecular Life Sciences
  41. CRISPR screening by AAV episome-sequencing (CrAAVe-seq): a scalable cell-type-specific in vivo platform uncovers neuronal essential genes
    Biswarathan Ramani, Indigo V.L. Rose, Noam Teyssier, Andrew Pan, Spencer Danner-Bocks, Tanya Sanghal, Lin Yadanar, Ruilin Tian, Keran Ma, Jorge J. Palop et al. · 2025 · Nature Neuroscience
  42. Cell-type resolved protein atlas of brain lysosomes identifies SLC45A1-associated disease as a lysosomal disorder
    Ali Ghoochani, Julia C. Heiby, Eshaan S. Rawat, Uche N. Medoh, Domenico Di Fraia, Wentao Dong, Marc Gastou, Mohit Rastogi, Vincent Hernandez, Kwamina Nyame et al. · 2026 · Cell
  43. Systematic exploration of dynamic splicing networks reveals conserved multistage regulators of neurogenesis
    Hong Ryul Han, Andrew J. Best, Ulrich Braunschweig, Nicholas Mikolajewicz, Jack Daiyang Li, Jonathan F. Roth, Fuad Chowdhury, Federica Mantica, Syed Nabeel‐Shah, Guillermo E. Parada et al. · 2022 · Molecular Cell
  44. Stem Cell Neurodevelopmental Solutions for Restorative Treatments of the Human Trunk and Spine
    Zachary T. Olmsted, Janet L. Paluh · 2021 · Frontiers in Cellular Neuroscience
  45. Benchmarking AI Models for <i>In Silico</i> Gene Perturbation of Cells
    Li, Chen, Gao, Haoxiang, She, Yuli, Bian, Haiyang, Chen, Qing, Liu, Kai, Wei, Lei, Zhang, Xuegong · 2024
  46. CRISPR‐Cas9 screening identified lethal genes enriched in necroptosis pathway and of prognosis significance in osteosarcoma
    Ling Cheng, Wei Xiong, Song Li, Gao Wang, Jie Zhou, Haoguang Li · 2023 · The Journal of Gene Medicine
  47. Identification of genetic modifiers enhancing B7-H3-targeting CAR T cell therapy against glioblastoma through large-scale CRISPRi screening
    Xing Li, Shiyu Sun, Wansong Zhang, Ziwei Liang, Yitong Fang, Tianhu Sun, Yong Wan, Xingcong Ma, Shu-Qun Zhang, Yang Xu et al. · 2024 · Journal of Experimental & Clinical Cancer Research
  48. Applying stem cells and CRISPR engineering to uncover the etiology of schizophrenia
    P. J. Michael Deans, Kristen Brennand · 2021 · Current Opinion in Neurobiology
  49. AP-4 regulates neuronal lysosome composition, function, and transport via regulating export of critical lysosome receptor proteins at the trans-Golgi network
    Piyali Majumder, Daisy Edmison, Catherine E. Rodger, Sruchi Patel, Evan Reid, Swetha Gowrishankar · 2022 · Molecular Biology of the Cell
  50. Mechanistic insights into the pathogenesis of microtubule‐targeting agent‐induced peripheral neuropathy from pharmacogenetic and functional studies
    Katherina C. Chua, Nura El‐Haj, Josefina Priotti, Deanna L. Kroetz · 2021 · Basic & Clinical Pharmacology & Toxicology
  51. Deficiency of the Lysosomal Protein CLN5 Alters Lysosomal Function and Movement
    Basak, Indranil, Hansen, Rachel A., Ward, Michael E., Hughes, Stephanie M. · 2021 · Biomolecules
  52. Investigational eIF2B activator DNL343 modulates the integrated stress response in preclinical models of TDP-43 pathology and individuals with ALS in a randomized clinical trial
    Brittany N. Flores, Seungyoon B. Yu, Isaac V. Cohen, Melania H. Fanok, Wei Luan, Romeo D. Maciuca, Linus D. Sun, Richard M. Tsai, Maurits F. J. M. Vissers, Lars Smits et al. · 2025 · Nature Communications
  53. Screening Platforms for Genetic Epilepsies—Zebrafish, iPSC-Derived Neurons, and Organoids
    Aleksandr Shcheglovitov, Randall Theodore Peterson · 2021 · Neurotherapeutics
  54. A human iPSC-derived inducible neuronal model of Niemann-Pick disease, type C1
    Anika Vinayak Prabhu, Insung Kang, Raffaella De Pace, Christopher A. Wassif, Hideji Fujiwara, Pamela J. Kell, Xuntian Jiang, Daniel S. Ory, Juan S. Bonifacino, Michael Emmerson Ward et al. · 2021 · BMC Biology
  55. CRISPR screening in hematology research: from bulk to single-cell level
    Sarah Meyers, Sofie Demeyer, Jan Cools · 2023 · Journal of Hematology & Oncology
  56. Alkenyl oxindole is a novel PROTAC moiety that recruits the CRL4DCAF11 E3 ubiquitin ligase complex for targeted protein degradation
    Ying Wang, Tianzi Wei, Man Zhao, Aima Huang, Fan Sun, Lu Chen, Risheng Lin, Yubao Xie, Ming Zhang, Shiyu Xu et al. · 2024 · PLoS Biology
  57. Methodologies and Challenges for CRISPR/Cas9 Mediated Genome Editing of the Mammalian Brain
    Hirofumi Nishizono, Ryohei Yasuda, Tal Laviv · 2020 · Frontiers in Genome Editing
  58. Simultaneous CRISPR screening and spatial transcriptomics reveals intracellular, intercellular, and functional transcriptional circuits
    Binan, Loϊc, Danquah, Serwah, Valakh, Vera, Simonton, Brooke, Bezney, Jon, Nehme, Ralda, Cleary, Brian, Farhi, Samouil L · 2023
  59. Poly-GR repeats associated with ALS/FTD gene C9ORF72 impair translation elongation and induce a ribotoxic stress response in neurons
    Daoyuan Dong, Zhe Zhang, Yini Li, Malgorzata J. Latallo, Shaopeng Wang, Blake Nelson, Rong Wu, Gopinath Krishnan, Fen‐Biao Gao, Bin Wu et al. · 2024 · Science Signaling
  60. Ciliary biology intersects autism and congenital heart disease
    Nia Teerikorpi, Kate E. McCluskey, Ethel Bader, Micaela C. Lasser, Sheng Wang, Catherine H. Nguyen, James D. Schmidt, Elina Kostyanovskaya, Nawei Sun, Jeanselle Dea et al. · 2025 · Development
  61. Lysosomal proteomics reveals mechanisms of neuronal APOE4-associated lysosomal dysfunction
    Einar Krogsaeter, Justin McKetney, Leopoldo Valiente‐Banuet, Angelica Marquez, Alexandra Willis, Zeynep Cakir, Erica J. Stevenson, Gwendolyn Μ. Jang, Antara T. Rao, Emmy Li et al. · 2025 · Autophagy
  62. Transcriptional-regulatory convergence across functional MDD risk variants identified by massively parallel reporter assays
    Bernard Mulvey, Joseph D. Dougherty · 2021 · Translational Psychiatry
  63. Application of CHyMErA Cas9-Cas12a combinatorial genome-editing platform for genetic interaction mapping and gene fragment deletion screening
    Michael Aregger, Kun Xing, Thomas Gonatopoulos-Pournatzis · 2021 · Nature Protocols
  64. Organoids as a tool to study homeostatic and pathological immune–epithelial interactions in the gut
    Emma Højmose Kromann, Ainize Peña‐Cearra, Joana F. Neves · 2024 · Clinical & Experimental Immunology
  65. Implementation and validation of single-cell genomics experiments in neuroscience
    Marco Colonna, Geneviève Konopka, Shane Antony Liddelow, Tomasz Jan Nowakowski, Rajeshwar B. Awatramani, Helen S. Bateup, Cathryn René Cadwell, Emre Caglayan, Jerry L. Chen, Jesse Gillis et al. · 2024 · Nature Neuroscience
  66. PIKfyve inhibition blocks endolysosomal escape of α-synuclein fibrils and spread of α-synuclein aggregation
    Stephanie K. See, Merissa Chen, Sophie Bax, Ruilin Tian, Amanda L. Woerman, Eric Tse, Isabel E. Johnson, Carlos Nowotny, Elise N. Muñoz, Janine Sengstack et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  67. Genetically modified organoids for tissue engineering and regenerative medicine
    Qinmeng Zhang, He Jin, Danji Zhu, Yunxuan Chen, Mengdie Fu, Shiyun Lu, Yuesheng Qiu, Guodong Zhou, Guoli Yang, Zhiwei Jiang · 2024 · Advances in Colloid and Interface Science
  68. Gene Modulation with CRISPR-based Tools in Human iPSC-Cardiomyocytes
    Julie Han, Emilia G. Entcheva · 2023 · Stem Cell Reviews and Reports
  69. CRISPR for neuroscientists
    Georgios Kalamakis, Randall J. Platt · 2023 · Neuron
  70. Massively parallel disruption of enhancers active in human neural stem cells
    Evan T. Geller, Mark A. Noble, Matheo Morales, Jake Gockley, Deena Emera, Severin Uebbing, Justin L. Cotney, James P. Noonan · 2024 · Cell Reports
  71. Integrating CRISPR Engineering and hiPSC-Derived 2D Disease Modeling Systems
    Kristina Rehbach, Michael B. Fernando, Kristen Brennand · 2020 · Journal of Neuroscience
  72. Convergence of autism proteins at the cilium
    Elina Kostyanovskaya, Micaela C. Lasser, Belinda Wang, James Schmidt, Ethel Bader, Chad Buteo, Juan Arbelaez, Aria Rani Sindledecker, Kate E. McCluskey, Octavio Castillo et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  73. Prevention of transgene silencing during human pluripotent stem cell differentiation
    Takeshi Uenaka, Alan Napole, A. Saha, Duo Sun, Angelina Singavarapu, Elizabeth Calzada, Jiahui Chen, Lena Erlebach, Amanda McQuade, Daniel M. Ramos et al. · 2026 · Cell stem cell
  74. Multiparameter phenotypic screening for endogenous TFEB and TFE3 translocation identifies novel chemical series modulating lysosome function
    Phillippa J. Carling, Brent James Ryan, William McGuinness, Shikha Kataria, Stewart W. Humble, Stefan Milde, James A. Duce, Nirav R. Kapadia, William J. Zuercher, John B. Davis et al. · 2022 · Autophagy
  75. Cell reprogramming therapy for Parkinson’s disease
    Wenjing Dong, Shuyi Liu, Shangang Li, Zhengbo Wang · 2023 · Neural Regeneration Research
  76. Surfaceome CRISPR screen identifies OLFML3 as a rhinovirus-inducible IFN antagonist
    Hong Mei, Zhao Zha, Wei Wang, Yusang Xie, Yuege Huang, Wenping Li, Dong Wei, Xinxin Zhang, Jia Xie, Jia Liu et al. · 2021 · Genome biology
  77. Commander complex regulates lysosomal function and is implicated in Parkinson’s disease risk
    Georgia Minakaki, Nathaniel Safren, Bernabé I. Bustos, Steven J Lubbe, Niccolò Emanuele Mencacci, Dimitri Krainc · 2025 · Science
  78. Robust virtual staining of landmark organelles with Cytoland
    Ziwen Liu, Eduardo Hirata-Miyasaki, Soorya Pradeep, Johanna V. Rahm, Christian Foley, Talon Chandler, Ivan E. Ivanov, Hunter O. Woosley, See-Chi Lee, Sudip Khadka et al. · 2025 · Nature Machine Intelligence
  79. Drosophila melanogaster as a model to study age and sex differences in brain injury and neurodegeneration after mild head trauma
    Changtian Ye, Joseph A. Behnke, Katherine R. Hardin, James Q. Zheng · 2023 · Frontiers in Neuroscience
  80. The response of Dual-leucine zipper kinase (DLK) to nocodazole: Evidence for a homeostatic cytoskeletal repair mechanism
    Laura DeVault, Chase Mateusiak, John Palucki, Michael R. Brent, Jeffrey Milbrandt, Aaron DiAntonio · 2024 · PLoS ONE
  81. Extracellular matrix proteolysis maintains synapse plasticity during brain development
    Haruna Nakajo, Ran Cao, Supriya A. Mula, Justin McKetney, Nicholas J. Silva, Kathy H. Li, Robert J. Chalkley, Lisa K. Randolph, Muskaan Shah, Indigo V.L. Rose et al. · 2025 · Nature Neuroscience
  82. Using the dCas9-KRAB system to repress gene expression in hiPSC-derived NGN2 neurons
    Aiqun Li, Samuel Cartwright, Alex Yu, Seok‐Man Ho, Nadine Schrode, P. J. Michael Deans, Marliette R. Matos, Meilín Fernández García, Kayla G. Townsley, Bin Zhang et al. · 2021 · STAR Protocols
  83. The motor system is exceptionally vulnerable to absence of the ubiquitously expressed superoxide dismutase-1
    Julien H. Park, Ulrika Nordström, Konstantinos Tsiakas, Isil Keskin, Christiane Elpers, Manoj Mannil, Raoul Heller, Melinda A. Nolan, Salam Alburaiky, Per Zetterström et al. · 2022 · Brain Communications
  84. Large-scale RNA-Seq mining reveals ciclopirox olamine induces TDP-43 cryptic exons
    Irika R. Sinha, Parker S. Sandal, Holly Spence, Grace D. Burns, Aswathy Peethambaran Mallika, Fatemeh Abbasinejad, Katherine E. Irwin, Anna Lourdes Cruz, Vania Wang, Shaelyn R Marx et al. · 2025 · Nature Communications
  85. Multiparametric Assays for Accelerating Early Drug Discovery
    Alexander Herholt, Sabrina Galinski, Philipp Emanuel Geyer, Moritz J. Rossner, Michael C. Wehr · 2020 · Trends in Pharmacological Sciences
  86. Modifier pathways in polyglutamine (PolyQ) diseases: from genetic screens to drug targets
    Marta Daniela Costa, Patrı́cia Maciel · 2022 · Cellular and Molecular Life Sciences
  87. CRISPRi gene modulation and all-optical electrophysiology in post-differentiated human iPSC-cardiomyocytes
    Julie Han, Yuli W. Heinson, Christianne J. Chua, Wei Liu, Emilia G. Entcheva · 2023 · Communications Biology
  88. Functional analysis of cancer-associated germline risk variants
    Laura N. Kellman, Poornima H. Neela, Suhas Srinivasan, Zurab Siprashvili, Ronald L. Shanderson, Audrey W. Hong, Deepti S. Rao, Douglas F. Porter, David L. Reynolds, Robin M. Meyers et al. · 2025 · Nature Genetics
  89. Autophagosomes anchor an AKAP11-dependent regulatory checkpoint that shapes neuronal PKA signaling
    Ashley Segura-Roman, Y. Rose Citron, Myungsun Shin, Nicole Sindoni, Alex Maya-Romero, Simon Rapp, Claire Goul, Joseph Douglas Mancias, Roberto Zoncu · 2025 · The EMBO Journal
  90. Manipulating and studying gene function in human pluripotent stem cell models
    Elisa Balmas, Federica Sozza, Sveva Bottini, Maria Luisa Ratto, Giulia Savoré, Silvia Becca, Kirsten E Snijders, Alessandro Bertero · 2023 · FEBS Letters
  91. Sequential CRISPR screening reveals partial NatB inhibition as a strategy to mitigate alpha-synuclein levels in human neurons
    Saranya Santhosh Kumar, Nima N. Naseri, Sarshan R. Pather, Erinc Hallacli, Alain Ndayisaba, Chris Buenaventura, Karen Acosta, Jennifer Roof, Hossein Fazelinia, Lynn A. Spruce et al. · 2024 · Science Advances
  92. TDP43 autoregulation gives rise to dominant negative isoforms that are tightly controlled by transcriptional and post-translational mechanisms
    Megan M. Dykstra, Kaitlin Weskamp, Nicolás Gómez, Jacob Waksmacki, Elizabeth M.H. Tank, M. Rebecca Glineburg, Allison G. Snyder, Emile S. Pinarbasi, Michael E. Bekier, Xingli Li et al. · 2025 · Cell Reports
  93. Engineering novel CRISPRi repressors for highly efficient mammalian gene regulation
    Andrew Kristof, Krithika Karunakaran, Christopher Allen, Paula Mizote, Sophie Briggs, Zixin Jian, Patrick Nash, John Blazeck · 2025 · Genome biology
  94. Mechanism of cytarabine-induced neurotoxicity
    Jiacheng Liu, Dongpeng Wang, Elsa Callén, Chuanyuan Chen, Santiago Noriega, Yafang Shang, David Schürmann, Yawei Song, Gokul N. Ramadoss, Raj Chari et al. · 2025 · Nature
  95. Genetically Engineering the Nervous System with CRISPR-Cas
    Alfredo Sandoval, Hajira Elahi, Jonathan E. Ploski · 2020 · eNeuro
  96. Applying gene‐editing technology to elucidate the functional consequence of genetic and epigenetic variation in Alzheimer’s disease
    Michael Schrauben, Emma Louise Dempster, Katie Lunnon · 2020 · Brain Pathology
  97. Microglial involvement in autism spectrum disorder: insights from human data and iPSC models
    Susanne Michels, Akash Shivling Mali, Henna Jäntti, Mohammad Rezaie, Tarja Malm · 2025 · Brain Behavior and Immunity
  98. Emerging Molecular Targets in Neurodegenerative Disorders: New Avenues for Therapeutic Intervention
    Ezgı Eroglu, Nuşin HARMANCI · 2025 · Basic & Clinical Pharmacology & Toxicology
  99. Myocardial reprogramming by HMGN1 underlies heart defects in trisomy 21
    Sanjeev S. Ranade, Feiya Li, Sean Whalen, Angelo Pelonero, Lin Ye, Yu Huang, Abigail Brand, Tomohiro Nishino, Rahul Mital, Ryan M. Boileau et al. · 2025 · Nature
  100. Impaired ribosome-associated quality control of C9orf72 arginine-rich dipeptide-repeat proteins
    Ashley Viera-Ortiz, Gregory G. Cajka, Olamide A. Olatunji, Bailey Mikytuck, Ophir Shalem, Edward B. Lee · 2022 · Brain